title: Management of neurologic disorders.
authors.affiliation: New York Blood Center, New York Medical College, Valhalla.
authors.forename: D
authors.initials: D
authors.lastname: Ciavarella
authors.forename: D
authors.initials: D
authors.lastname: Wuest
authors.forename: R G
authors.initials: RG
authors.lastname: Strauss
authors.forename: R O
authors.initials: RO
authors.lastname: Gilcher
authors.forename: D O
authors.initials: DO
authors.lastname: Kasprisin
authors.forename: D D
authors.initials: DD
authors.lastname: Kiprov
authors.forename: H G
authors.initials: HG
authors.lastname: Klein
authors.forename: B C
authors.initials: BC
authors.lastname: McLeod
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009422:Nervous System Diseases / Q000188:drug therapy / Q000628:therapy*; D009468:Neuromuscular Diseases / Q000628:therapy; D010257:Paraneoplastic Syndromes / Q000628:therapy; D010951:Plasma Exchange; D011618:Psychotic Disorders / Q000188:drug therapy / Q000628:therapy
chemical_list: D014150:Antipsychotic Agents; D007166:Immunosuppressive Agents